Vivo Capital Surplus Fund VIII, L.P. — SEC Form 4 filings

SEC reporting owner CIK 1628048. 1 Form 4 filing on record with FilingPulse; latest filed 2024-04-03.

Transaction summary — filings shown

Covers all 1 filing on record, filed 2024-04-03 to 2024-04-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Terns Pharmaceuticals, Inc. (TERN)10% owner19 legs · 420,663 sh · $2,796,859

Form 4 filings — Vivo Capital Surplus Fund VIII, L.P.

FiledFormIssuerReported transactionsSource
2024-04-034Terns Pharmaceuticals, Inc. (TERN)
jointly with Vivo Opportunity, LLC, Vivo Opportunity Fund Holdings, L.P., Vivo Capital VIII, LLC, Vivo Capital Fund VIII, L.P.
Sale (S): 136,255 @ $6.99 · Sale (S): 39,411 @ $6.99 · Sale (S): 5,451 @ $6.99 · Sale (S): 76,346 @ $6.65 · Sale (S): 22,084 @ $6.65 · Sale (S): 3,050 @ $6.65 · +3 moreEDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1628048 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →